Ahmed A Suleiman

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Magnetic Resonance Imaging

Ulcerative Colitis

Top Venues

Clinical pharmacology and therapeutics

Clinical drug investigation

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics 116 (3) (2024)
Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics (2024)
Neha Thakre, Ronilda R D'Cunha, Aline Goebel, Wei Liu, Yinuo Pang, Ahmed A Suleiman
Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis. Rheumatology and therapy 9 (6) (2022)
Mohamed Badawi, Xin Chen, Patrick Marroum, Ahmed A Suleiman, Sven Mensing, Anette Koenigsdorfer, Julia Teresa Schiele, Tammy Palenski, Divya Samineni, David Hoffman, Rajeev M Menon, Ahmed Hamed Salem
Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet. Clinical drug investigation 42 (8) (2022)